BLAU FARMACÊUTICA S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.89 BRL | +5.36% |
|
+0.83% | -33.64% |
| 20/03 | Transcript : Blau Farmacêutica S.A., Q4 2023 Earnings Call, Mar 20, 2024 | |
| 19/03 | Blau Farmacêutica S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on Blau Farmacêutica S.A.
Price target over the last 5 years
History of analyst recommendation changes
28080196d79c9b.zTVdAxVFmH0Ed6qwKqve5x4_ffNrXFMcylrhdqiCS50.vn8pMlID6Q58Me_6XtzmkjNITLVbHiN7sAimOdzuKKunQBJZRBPvNk4ikg~8845023da4d43619997488131cd05d7e
Analysts' Consensus
Sell
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
7
Last Close Price
10.89
BRL
Average target price
13.57
BRL
Spread / Average Target
+24.62%
High Price Target
18
BRL
Spread / Highest target
+65.29%
Low Price Target
10
BRL
Spread / Lowest Target
-8.17%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- BLAU3 Stock
- Consensus Blau Farmacêutica S.A.
